News

Biocon Biologics And Civica Partner To Expand Access To Insulin Aspart In The US

Kristen Butler

Published

on

Biocon Biologics

Biocon Biologics Ltd. and Civica, Inc. have announced a strategic collaboration to improve access and affordability of Insulin Aspart in the United States.

The partnership aims to address the growing need for affordable insulin amid rising diabetes rates, with Biocon Biologics supplying Insulin Aspart drug substance and Civica producing the finished drug product at its Petersburg, Va., facility.

The initiative comes as insulin costs remain a significant challenge for patients. According to Civica CEO Ned McCoy, affordability is a critical issue, with one in five people with diabetes having skipped, delayed, or used less insulin than needed due to financial constraints.

“Civicas mission is to help people who need access to necessary generic and biosimilar medicines at affordable prices,” McCoy said. “This partnership with Biocon Biologics will allow us to provide patients with Insulin Aspart through our U.S.-based manufacturing operations.”

Biocon Biologics CEO Shreehas Tambe emphasized the companys commitment to expanding patient access to high-quality biosimilars.

“As a fully integrated global biologics company, Biocon Biologics is uniquely positioned to drive commercial success through tailored go-to-market strategies that create lasting value for all stakeholders,” Tambe said. “Our collaboration with Civica reflects this commitment, enabling us to expand patient access to Insulin Aspart in the United States while reinforcing our dedication to serving the growing needs of people living with diabetes.”

This agreement is separate from Biocon Biologics own Insulin Aspart drug product, which is currently under U.S. Food and Drug Administration (FDA) review.

With 38.4 million people in the U.S. living with diabetes — 11.6% of the population, according to the CDC — the demand for affordable insulin is greater than ever. An additional 97.6 million Americans have been identified as prediabetic, highlighting the urgent need for cost-effective treatment options.

Biocon Biologics Ltd. is a fully integrated global biosimilars company focused on affordable healthcare solutions. The company has commercialized nine biosimilars across 120+ countries, with a pipeline targeting diabetology, oncology, immunology, and ophthalmology.

Civica, Inc., a non-profit pharmaceutical company, was founded in 2018 to address persistent drug shortages. Its Petersburg, Va., facility is designed to produce prefilled insulin pens and vials, ensuring a stable and affordable supply for patients in need.

Trending News

Exclusive3 days ago

Robert De Niro ‘Grappling’ With ‘Grief’ After Back-to-Back Losses: ‘Only So Much a Person Can Take’

Tragedy3 days ago

Four Dead at Elementary School After Students Ate Suspected Poisoned Oranges

Peyton Knight Peyton Knight
Influencer4 days ago

Texas Woman Sparks Debate After Revealing She ‘Always’ Packs a Pistol Before Going for Runs

Crime4 days ago

Ex-President Obama’s Former CIA Director John Brennan’s Son Arrested on Disturbing Federal Charge

Judge Grants Bryan Kohberger Two 2027 Hearings Judge Grants Bryan Kohberger Two 2027 Hearings
Crime5 days ago

Surviving Roommate in Idaho College Murders Moved 9 Times Amid Threats and Fears for Her Safety

Crime3 days ago

Elementary School Bake Sale Turned to Chaos After Batteries Were Found in Muffins That Kids Ate

Animals5 days ago

‘Trashed Panda’ Raccoon Rakes in $300K for Shelter One Year After His Liquor Store Bender

Travel4 days ago

TSA Uncovers $27K in Suspected Cocaine Hidden in Coffee Container After Checking Passenger’s Luggage

Politics5 days ago

John Cusack Calls Sean Hannity a ‘Bottomless Pit of Self Loathing’ for Slamming Pope Leo XIV

News3 days ago

Doctor Sued By Second Patient Accusing Him of Injecting Rubbing Alcohol Instead of Lidocaine

Crime4 days ago

Man Dies After Neighbor Offers Him a Bomb Disguised as a Dumpling That Exploded in His Mouth

Travel4 days ago

National Weather Service Outage Falsely Reported Amid FAA Nationwide Grounding